Met Amplification

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-03-10
Clinical Trial Update: Lorlatinib Combinations in Lung Cancer [Phase 1, Phase 2]
Phase 1/2 trial exploring lorlatinib combinations in lung cancer with ALK translocations and related resistant/metabolic alterations; status…